Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             29 results found
no title author magazine year volume issue page(s) type
1 Adjuvant radiation therapy in small ductal carcinoma in situ Cho, Won Kyung
2019
43 C p. 55-58
article
2 Agreement between digital breast tomosynthesis and pathologic tumour size for staging breast cancer, and comparison with standard mammography Marinovich, M. Luke
2019
43 C p. 59-66
article
3 A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer Velázquez, Carolina
2019
43 C p. 91-96
article
4 Category “viewpoints and debates” Is trastuzumab as a single agent obsolete in early breast cancer? Yes Bonnefoi, Hervé
2019
43 C p. 146-148
article
5 Circulating renin-angiotensin system-regulating specific aminopeptidase activities in pre- and post- menopausal women with breast cancer treated or not with neoadyuvant chemotherapy. A two years follow up study Ramírez-Exposito, María Jesús
2019
43 C p. 28-30
article
6 Clinico-pathological characteristics among South African women with breast cancer receiving anti-retroviral therapy for HIV Phakathi, Boitumelo
2019
43 C p. 123-129
article
7 Clinicopathological characteristics of metaplastic breast cancer – analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types Budzik, M.P.
2019
43 C p. 135-141
article
8 Consumer and clinician perspectives on personalising breast cancer prevention information Keogh, L.A.
2019
43 C p. 39-47
article
9 Corrigendum to “Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up” [Breast 41 (October 2018) 74–81] Arraras, Juan Ignacio
2019
43 C p. 7
article
10 EarlyR signature predicts response to neoadjuvant chemotherapy in breast cancer Buechler, Steven A.
2019
43 C p. 74-80
article
11 Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer Ren, Yi-Xing
2019
43 C p. 97-104
article
12 Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program Jiang, Huan
2019
43 C p. 105-112
article
13 Hepatic arterial therapy with oxaliplatin and systemic capecitabine for patients with liver metastases from breast cancer Lindgaard, S.C.
2019
43 C p. 113-119
article
14 How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2) Montagna, Giacomo
2019
43 C p. 18-21
article
15 Is trastuzumab as a single agent obsolete in early breast cancer? No Bianchini, Giampaolo
2019
43 C p. 142-145
article
16 MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators Ljepoja, Bojan
2019
43 C p. 31-38
article
17 Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma Haque, Waqar
2019
43 C p. 67-73
article
18 Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre Mitus, J.W.
2019
43 C p. 85-90
article
19 Pure or mixed type invasive lobular carcinoma; are they different from each other? Altundag, Kadri
2019
43 C p. 151
article
20 Reply to the letter “Pure or mixed type invasive lobular carcinoma; are they different from each other?” Haque, Waqar
2019
43 C p. 151-152
article
21 Reply to the letter “Safety of fertility preservation in women with breast cancer” Lambertini, Matteo
2019
43 C p. 149-150
article
22 Ribociclib in hormone-receptor-positive advanced breast cancer: Establishing a value-based cost in China Wan, XiaoMin
2019
43 C p. 1-6
article
23 Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors Chang, Jee Suk
2019
43 C p. 48-54
article
24 Safety of fertility preservation in women with breast cancer Rodriguez-Wallberg, Kenny A.
2019
43 C p. 149
article
25 Sexuality, a topic that surgeons should discuss with women before risk-reducing mastectomy and breast reconstruction Dikmans, Rieky E.G.
2019
43 C p. 120-122
article
26 Targeting CDK4/6 pathways and beyond in breast cancer Ribnikar, Domen
2019
43 C p. 8-17
article
27 The role of histone deacetylase inhibitors in metastatic breast cancer Zucchetti, Bruna
2019
43 C p. 130-134
article
28 Treatment patterns and clinical outcomes among patients receiving palbociclib in combination with an aromatase inhibitor or fulvestrant for HR+/HER2-negative advanced/metastatic breast cancer in real-world settings in the US: Results from the IRIS study Taylor-Stokes, Gavin
2019
43 C p. 22-27
article
29 Why upfront use of CDK inhibitors for the treatment of advanced breast cancer may be wasteful, and how we can increase their value Niraula, Saroj
2019
43 C p. 81-84
article
                             29 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands